India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Urges Innovators to produce quality products that can be deployed at scale
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources
He urged the dignitaries to collaboratively work on the identified domains of improvement and make detailed reports on them
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
Subscribe To Our Newsletter & Stay Updated